Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001213900-20-012897
Filing Date
2020-05-19
Accepted
2020-05-19 11:44:51
Documents
1
Effectiveness Date
2020-05-19
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11287
  Complete submission text file 0001213900-20-012897.txt   12606
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: D | Act: 33 | File No.: 021-367265 | Film No.: 20892515
SIC: 2834 Pharmaceutical Preparations